Global Structural Heart Devices
Market is expected to reach
USD 9.1 billion by 2025, based on a new report by Grand View Research, Inc.
The market is expected to witness an exponential growth over the next 8 years
due to the rapid increase in cardiovascular conditions and increasing power of
healthcare expenditure.
The defects are mostly present at birth, thereby directly
affecting the under-5 mortality rate of a country. Therefore, rigorous actions
are being undertaken by various government bodies across the globe to increase
access to treatment. The Centers for Disease Control and Prevention have a
public action plan to efficient management of cardiac conditions.
In addition, other organizations are working on improving
the scenario for structural heart diseases treatment. For instance, in November
2016, the Cardiovascular Research Foundation (CRF) announced a launch of a
journal focusing on diagnosis and treatment of structural heart defects. It was
titled Structural Heart: The Journal of the Heart Team and is
expected to be launched in May 2017. This is expected to trigger research &
development activities along with capital invested in this field, resulting in
technological advancements.
Access Full Research Report on Structural Heart Devices
Market: http://www.grandviewresearch.com/industry-analysis/structural-heart-devices-market
Further key findings from the study suggest:
- Surgical
Aortic Valve Replacement (SAVR) dominated the market in 2016, closely
followed by Trans catheter Aortic Valve Replacement (TAVR). It can be
attributed to the longest presence of the technique in the treatment
regimen of aortic stenosis
- Left
Atrial Appendage Closure (LAAC) is anticipated to be one of the fastest
growing segment owing to the minimally invasive nature of the procedure.
It also helps in reduction of risk of stroke, thus is projected to have a
higher demand
- Geographically,
North America held the largest market share in 2016 and is expected to
maintain its position during the forecast period. High prevalence of
cognitive heart diseases is the key reason for this dominance. Moreover,
the mandatory CCHD screening for new-borns imposed by the Centers for
Disease Control and Prevention (CDC) and American Academy of Pediatrics
(AAP) in September 2014 also contributes to the growth in this region
- Asia
Pacific is also expected to witness a rapid growth over the forecast
period. The improved access and capability for treatments in this region
is the key reason for this growth
- Some
of the key players are Medtronic, ST. JUDE MEDICAL, Boston Scientific
Corporation, CardioKinetix, Comed BV, Edwards Lifesciences Corporation,
LivaNova PLC, Abbott Laboratories, JenaValve Technology, Inc., and
Biomerics
View More Related
Reports From Same Category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare
Grand View Research
has segmented the Structural Heart Devices Market by type and region:
Type Outlook (Market Revenue in USD Million, 2014 - 2025)
- SAVR
- TAVR
- Mitral
Repair (Annuloplasty)
- LAAC
Regional Outlook (Market Revenue in USD Million, 2014 -
2025)
- North
America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa
- South
Africa
View Blog on Global Structural Heart Devices Market By Grand View Research: http://www.grandviewresearch.com/blog/structural-heart-devices-market-size-share
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry
James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For more Information visit us: www.grandviewresearch.com